Exhitibitors at CPHI Japan
Our company member Alex Gruman and Patriapharma-Japan office manager Shigeru Oshikiri are present as exihibitors on the CPHI Japan from April 19-21
Hungary-Japan Economic Club
Our company became a member of the Hungary-Japan Economic Club (Magyar-Japán Gazdasági Klub)
Arab Health Expo
Our Business Development director, Alex Gruman represented our company in Dubai on the Arab Health Expo.
15 supported employer’s informative obligation
Name of beneficiary: Pátriapharma Gyógyszergyártó Kft.Amount of grant: 1.591.200 HUF Presentation of the training: Haladok a korral– IT knowledges: word and excel (24 hours), with 2 groups, in 24 hours with 15 participantsPurpose of the training: The participants get to know the word processing...
Development of manufacturing technology for three pharmaceutical ingredients
For three active pharmaceutical ingredients (Atracurium Besylate, Biperiden HCl, Cisatracurium Besylate) we plan to develop a manufacturing technology first on laboratory scale followed by pilot plant and finally on production scale. The quality of the pharmaceutical ingredients manufactured with this technology shall meet both the quality...
Establishment of a Japanese representative office
A Cf Pharma exclusive commercial partner, Patriapharma won the below grant for establishing its Japanese subsidiary: The project “Establishment of a representative office in Japan to increase the volume of trade with Asian countries” was funded by the Ministry of Foreign Affairs and Trade’s Export Promotion...
Start of a new year
We have started the new year with welcoming Mr. Alex Gruman into the Business development director role. Alex will share his 35+ years experience in pharma business where he served different CDMOs as managing director as well as his long period within Rhone Poulenc group (Rhodia, Aventis, Merial and later Sanofi).
Atracurium
Due to the Covid-pandemic a large volume of Atracurium was needed worldwide. Government agencies and private companies ordered huge amounts from the API. Atracurium is a muscle-relaxant mostly used for respiratory infections during the anesthesia procedure. It was a humanitarian responsibility to produce the necessary amount from this very...
GMP Certificate for CF Pharma Ltd.
Successful renewal of the GMP Certificate for CF Pharma Ltd. Three members from the National Institute of Pharmacy (Hungarian: Országos Gyógyszerészeti Intézet, known as: „OGYI”) audited our companies for GMP compliance on 5 APIs (Atracurium besylate, Cabergoline, Cisatracurium besylate, Biperiden HLC.) Our company successfully received the...
CPHI Worldwide in Frankfurt
Our company was represented on the CPHI Worldwide in Frankfurt. This was the first major pharmaceutical global event after the Covid pandemic, which was held live. It was a great pleasure to meet with new clients and discuss current and future business endeavours.
